Bibliometrics and visualization analysis of esophageal cancer surgery-related researches_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

ZHANG Shaoyuan , LIN Miao , WANG Hao ,  TAN Lijie

Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China;

Corresponding?author：

TAN Lijie, Email: tan.lijie@zs-hospital.sh.cn

Keywords：

Esophageal cancer surgery; esophagectomy; bibliometrics; visualization

DOI：

10.7507/1007-4848.202205053

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the current status of esophageal cancer surgery-related researches using bibliometric methodologies and identify the trend and hotspots. Methods The Chinese and English literature was collected from Web of Science and CNKI from inception of each database to April 1, 2022. VOSviewer 1.6.18 and CiteSpace 6.1 were applied to cluster the authors, institutions, and keywords. For social network and time series analysis, Excel, GraphPad, and R 4.0.3 were used to visualize the literature on esophageal cancer surgery. Results Finally, 19 566 English literature and 19 872 Chinese literature was included. The results demonstrated that the annual publishing of both Chinese and English literature increased over time, with English literature increasing rapidly and Chinese literature maintaining an average number of above 1 000 per year from 2011 to 2019. Researches were predominantly centered in Europe, the United States, Japan, South Korea, and China. China's researches in the field of surgical treatment in esophageal cancer lacked international collaboration, which began later than East Asian countries such as Japan and South Korea and had less influence. From the keyword perspective, previous researches on surgical treatment of esophageal cancer mostly focused on surgical techniques, complications, and comprehensive perioperative therapy. Both Chinese and English literature showed that the prevalence of keywords such as minimally invasive surgery, comprehensive treatment, and clinical trials increased dramatically during the recent years, indicating that these fields may represent the future directions and research trends. Conclusion Compared to East Asia countries, such as Japan and South Korea, Chinese esophageal cancer surgery-related researches are relatively lacking. The research direction and field are similar to those in developed countries such as the United States and Europe. Future attention may be focused on minimally invasive treatment, comprehensive treatment, and clinical trials associated with surgical treatment of esophageal cancer.

Citation： ZHANG Shaoyuan, LIN Miao, WANG Hao, TAN Lijie. Bibliometrics and visualization analysis of esophageal cancer surgery-related researches. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(12): 1594-1600. doi: 10.7507/1007-4848.202205053 Copy

1.	鄭榮壽, 孫可欣, 張思維, 等. 2015年中國惡性腫瘤流行情況分析. 中華腫瘤雜志, 2019, 41(1): 19-28.
2.	LEWIS I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg, 1946, 34: 18-31.
3.	Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg, 1999, 230(3): 392-400.
4.	Pritchard J. Statistical-bibliography or bibliometrics? 1969, 25(4): 348-349.
5.	Hutchins BI, Baker KL, Davis MT, et al. The NIH Open Citation Collection: A public access, broad coverage resource. PLoS Biol, 2019, 17(10): e3000385.
6.	鄭文暉. 文獻計量法與內容分析法的比較研究. 情報雜志, 2006, 25(5): 31-33.
7.	朱慶華, 李亮. 社會網絡分析法及其在情報學中的應用. 情報理論與實踐, 2008, 31(2): 6.
8.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
9.	van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial. Ann Surg, 2019, 269(4): 621-630.
10.	Tagkalos E, van der Sluis PC, Berlth F, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer, 2021, 21(1): 1060.
11.	Li B, Zhang Y, Miao L, et al. Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: Long-term outcomes of a randomized clinical trial. J Thorac Oncol, 2021, 16(2): 310-317.
12.	Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg, 2021, 161(3): 836-843.
13.	Wang H, Tang H, Fang Y, et al. Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: A randomized clinical trial. JAMA Surg, 2021, 156(5): 444-451.
14.	Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med, 2019, 380(2): 152-162.
15.	van Workum F, Verstegen MHP, Klarenbeek BR, et al. Intrathoracic vs cervical anastomosis after totally or hybrid minimally invasive esophagectomy for esophageal cancer: A randomized clinical trial. JAMA Surg, 2021, 156(7): 601-610.
16.	di Pietro M, Canto MI, Fitzgerald RC. Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: Screening, diagnosis, and therapy. gastroenterology, 2018, 154(2): 421-436.
17.	Yasuda T, Shiraishi O, Iwama M, et al. Novel esophageal reconstruction technique via transmediastinal route from posterior to anterior mediastinum after esophagectomy. J Thorac Cardiovasc Surg, 2018, 156(2): 859-866.
18.	Shen Y, Zhang Y, He M, et al. Advancing gastroscope from intraluminal to extraluminal dissection: Primary experience of laparo-gastroscopic esophagectomy. Ann Surg, 2022, 275(4): e659-e663.

1. 鄭榮壽, 孫可欣, 張思維, 等. 2015年中國惡性腫瘤流行情況分析. 中華腫瘤雜志, 2019, 41(1): 19-28.
2. LEWIS I. The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg, 1946, 34: 18-31.
3. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg, 1999, 230(3): 392-400.
4. Pritchard J. Statistical-bibliography or bibliometrics? 1969, 25(4): 348-349.
5. Hutchins BI, Baker KL, Davis MT, et al. The NIH Open Citation Collection: A public access, broad coverage resource. PLoS Biol, 2019, 17(10): e3000385.
6. 鄭文暉. 文獻計量法與內容分析法的比較研究. 情報雜志, 2006, 25(5): 31-33.
7. 朱慶華, 李亮. 社會網絡分析法及其在情報學中的應用. 情報理論與實踐, 2008, 31(2): 6.
8. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
9. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial. Ann Surg, 2019, 269(4): 621-630.
10. Tagkalos E, van der Sluis PC, Berlth F, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer, 2021, 21(1): 1060.
11. Li B, Zhang Y, Miao L, et al. Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: Long-term outcomes of a randomized clinical trial. J Thorac Oncol, 2021, 16(2): 310-317.
12. Sihag S, Ku GY, Tan KS, et al. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer. J Thorac Cardiovasc Surg, 2021, 161(3): 836-843.
13. Wang H, Tang H, Fang Y, et al. Morbidity and mortality of patients who underwent minimally invasive esophagectomy after neoadjuvant chemoradiotherapy vs neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma: A randomized clinical trial. JAMA Surg, 2021, 156(5): 444-451.
14. Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer. N Engl J Med, 2019, 380(2): 152-162.
15. van Workum F, Verstegen MHP, Klarenbeek BR, et al. Intrathoracic vs cervical anastomosis after totally or hybrid minimally invasive esophagectomy for esophageal cancer: A randomized clinical trial. JAMA Surg, 2021, 156(7): 601-610.
16. di Pietro M, Canto MI, Fitzgerald RC. Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: Screening, diagnosis, and therapy. gastroenterology, 2018, 154(2): 421-436.
17. Yasuda T, Shiraishi O, Iwama M, et al. Novel esophageal reconstruction technique via transmediastinal route from posterior to anterior mediastinum after esophagectomy. J Thorac Cardiovasc Surg, 2018, 156(2): 859-866.
18. Shen Y, Zhang Y, He M, et al. Advancing gastroscope from intraluminal to extraluminal dissection: Primary experience of laparo-gastroscopic esophagectomy. Ann Surg, 2022, 275(4): e659-e663.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Bibliometrics and visualization analysis of esophageal cancer surgery-related researches

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content